首页> 外文期刊>Molecular therapy: the journal of the American Society of Gene Therapy >AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence
【24h】

AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence

机译:包含rDNA同源性的AAV载体显示出增加的染色体整合和转基因持久性

获取原文
获取原文并翻译 | 示例
           

摘要

Although recombinant adeno-associated viral (rAAV) vectors are promising tools for gene therapy of genetic disorders, they remain mostly episomal and hence are lost during cell replication. For this reason, rAAV vectors capable of chromosomal integration would be desirable. Ribosomal DNA (rDNA) repeat sequences are overrepresented during random integration of rAAV. We therefore sought to enhance AAV integration frequency by including 28S rDNA homology arms into our vector design. A vector containing ~1 kb of homology on each side of a cDNA expression cassette for human fumarylacetoacetate hydrolase (FAH) was constructed. rAAV of serotypes 2 and 8 were injected into Fah-deficient mice, a model for human tyrosinemia type 1. Integrated FAH transgenes are positively selected in this model and rDNA-containing AAV vectors had a ~30× higher integration frequency than controls. Integration by homologous recombination (HR) into the 28S rDNA locus was seen in multiple tissues. Furthermore, rDNA-containing AAV vectors for human factor IX (hFIX) demonstrated increased transgene persistence after liver regeneration. We conclude that rDNA containing AAV vectors may be superior to conventional vector design for the treatment of genetic diseases, especially those associated with increased hepatocyte replication.
机译:尽管重组腺相关病毒(rAAV)载体是用于遗传疾病基因治疗的有前途的工具,但它们大多保持游离状态,因此在细胞复制过程中会丢失。由于这个原因,需要能够进行染色体整合的rAAV载体。核糖体DNA(rDNA)重复序列在rAAV的随机整合过程中被过度代表。因此,我们试图通过将28S rDNA同源臂纳入我们的载体设计来提高AAV整合频率。构建了一个在人反丁烯酸乙酰乙酸酯水解酶(FAH)的cDNA表达盒两侧各具有〜1 kb同源性的载体。将2型和8型血清型rAAV注射到1型人类酪氨酸血症模型Fah缺陷小鼠中,在该模型中阳性选择了整合的FAH转基因,并且含rDNA的AAV载体的整合频率比对照组高约30倍。在多个组织中观察到通过同源重组(HR)整合到28S rDNA基因座中。此外,人类再生因子IX(hFIX)的含rDNA的AAV载体显示出肝脏再生后转基因持续性增加。我们得出的结论是,包含rDNA的AAV载体在遗传疾病,尤其是与肝细胞复制增加相关的遗传疾病的治疗中可能优于常规载体设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号